Clinical Controversies: Management of the Axilla in Multidisciplinary Care
Session Details
This session will explore strategies for de-escalating axillary surgery and regional nodal radiation after neoadjuvant chemotherapy in clinically node-positive patients, and how these approaches will influence adjuvant therapy decisions in HR+/HER2- breast cancer.
Presentation numberCT2-01
De-escalation of axillary surgery after NAC in clinically node positive patients
Giacomo Montagna, Memorial Sloan Kettering Cancer Center, New York, NY
Presentation numberCT2-02
De-escalation of regional nodal radiation after NAC in clinically node positive patients
Lori Pierce, University of Michigan, Ann Arbor, MI
Presentation numberCT2-03
Adjuvant therapy decisions in HR+HER2- breast cancer in the era of axillary de-escalation
Sherry Shen, Memorial Sloan Kettering Cancer Center, New York, NY